Serial #88513447
LIVE

Serial Number

88513447

Owner

CantonBio AG

Attorney

Yue (Robert) Xu

First Use Date

Jun 7, 2016

Filing Date

Jul 14, 2019

Add to watchlist:

No watchlists yet
View on USPTO

Serial #88513447 Trademark

Serial Number: 88513447 • Registration: 6154613

Serial #88513447 is a trademark filed by CantonBio AG on July 14, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

CantonBio AG (4 trademarks)

Marktgasse 32
3011 Bern - , CH

Entity Type: 99

Trademark Details

Filing Date

July 14, 2019

Registration Date

September 15, 2020

First Use Anywhere

June 7, 2016

First Use in Commerce

June 7, 2016

Published for Opposition

December 24, 2019

Goods & Services

Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-inflammatories, anti-virals, anti-infectives, immunosuppressants and pharmaceutical antibodies; pharmaceuticals, namely, preparations for antibody and antibody-derivative development; pharmaceuticals, namely, antibodies and proteins for the treatment of oncological and autoimmune diseases and disorders; cytokine preparations and antibodies in the nature of pharmaceutical preparations for the treatment of oncological and autoimmune diseases and disorders; pharmaceutical preparations, namely, immuno- therapeutics and cytokines for the treatment of oncological and autoimmune diseases and disorders; diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; medicines for the treatment of gastrointestinal diseases, for human purposes; pharmaceutical products for the prevention and treatment of cancer, for human purposes; tumor suppressing agents, for human purpose; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for peripheral nervous system; vaccines; diagnostic preparations for medical purposes; chemical preparations for medical purposes, namely, for treating cancer; nutritional supplements; biocides; surgical glues

Proteins for use in the manufacture of food supplements; proteins for the food industry; protein for use in the manufacture of cosmetics; protein in raw material form for scientific and medical research; protein for industrial use; animal albumen for use in the manufacture of skin care product; animal albumen as a raw material for industrial use; diagnostic preparations other than for medical or veterinary purposes; biological preparations for use in industry and science; biological preparation for use in cell cultures other than for medical or veterinary use; cultures of microorganisms, other than for medical and veterinary use; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes; biochemical catalysts; stem cells, other than for medical or veterinary purposes

Biological research; medical and scientific research, namely, conducting clinical trials for others; research and development services in the field of antibodies; biotechnology research; testing of pharmaceuticals; analysis of the mode of action of chemical combinations on animals; bacteriological research; scientific laboratory services; scientific research; biomedical research services

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 15, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Sep 15, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 14, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 13, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jul 24, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 24, 2020 AITU
USE AMENDMENT FILED
Jul 5, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 5, 2020 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 18, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 24, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 24, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 4, 2019 NONP
ASSIGNED TO LIE
Nov 20, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 16, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 1, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 31, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 30, 2019 GNRN
NON-FINAL ACTION E-MAILED
Sep 30, 2019 GNRT
NON-FINAL ACTION WRITTEN
Sep 30, 2019 CNRT
ASSIGNED TO EXAMINER
Sep 30, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 20, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 19, 2019 NWOS
NEW APPLICATION ENTERED
Jul 17, 2019 NWAP